-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Vowrzi8MXrlXMiyu5EoxwX2LEdU3RPU5nEqNTISve7EHva82so+g7NECo2pNRYDO Rf66ud/08LXlyhNsoujM1Q== 0001266375-07-000020.txt : 20070220 0001266375-07-000020.hdr.sgml : 20070219 20070220150658 ACCESSION NUMBER: 0001266375-07-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070215 FILED AS OF DATE: 20070220 DATE AS OF CHANGE: 20070220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Boyd Thomas A CENTRAL INDEX KEY: 0001327433 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 07635258 BUSINESS ADDRESS: BUSINESS PHONE: (914) 789-2800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-02-15 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001327433 Boyd Thomas A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 Sr. VP, Product Dev. Common Stock 2007-02-15 4 M 0 4000 17.19 A 37676 D Common Stock 2007-02-15 4 S 0 4000 29.974 D 33676 D Non-Qualified Stock Option (right to buy) 17.19 2007-02-15 4 M 0 4000 0 D 2005-01-17 2010-01-18 Common Stock 4000 8000 D Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan. Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer. The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer. Thomas A. Boyd 2007-02-20 -----END PRIVACY-ENHANCED MESSAGE-----